Evidence map›Paper›PMID 38611853›Full record

ReviewMolecules (Basel, Switzerland)2024

Recent Advances in Gold Nanocluster-Based Biosensing and Therapy: A Review.

Lu Yang, Pengqi Hou, Jingyi Wei, Bingxin Li, Aijun Gao, Zhiqin Yuan

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lu YangCollege of Chemistry, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China.
Pengqi HouCollege of Chemistry, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China.
Jingyi WeiCollege of Chemistry, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China.
Bingxin LiCollege of Chemistry, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China.
Aijun GaoCollege of Chemistry, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China.
Zhiqin YuanCollege of Chemistry, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China.ORCID 0000-0002-9715-4449

Funding

National Natural Science Foundation of China 22074005Natural Science Foundation of Beijing Municipality 2202038
6 · The paper itself

Abstract

Gold nanoclusters (Au NCs) with bright emission and unique chemical reactivity characters have been widely applied for optical sensing and imaging. With a combination of surface modifications, effective therapeutic treatments of tumors are realized. In this review, we summarize the recently adopted biosensing and therapy events based on Au NCs. Homogeneous and fluorometric biosensing systems toward various targets, including ions, small molecules, reactive oxygen species, biomacromolecules, cancer cells, and bacteria, in vitro and in vivo, are presented by turn-off, turn-on, and ratiometric tactics. The therapy applications are concluded in three aspects: photodynamic therapy, photothermal therapy, and as a drug carrier. The basic mechanisms and performances of these systems are introduced. Finally, this review highlights the challenges and future trend of Au NC-based biosensing and therapy systems.

Indexed as

PhotochemotherapyDrug CarriersFluorometryGoldPhotothermal TherapyDrug CarriersGoldbiosensingfluorescencegold nanoclustersimagingtherapy

Identifiers

PMID38611853
PMCPMC11013830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.